Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Appeals Court Rehearing Rejected In Teva-GSK Skinny-Label Saga
Split Federal Circuit Refuses ‘En Banc’ Rehearing Of Labeling Carve-Out Case
Feb 14 2022
•
By
Dave Wallace
The appeals court refused to rehear the case on labelling carve-outs
More from Legal & IP
More from Generics Bulletin